Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity
The present invention relates to a lyophilized composition comprising killed cancer cells with substantially retained immunogenicity and morphology, an intracellular cryopreservative such as trehalose and an extracellular cryopreservative such as polyvinylpyrrolidone. The present invention also rela...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Singh Satinder Desai Nirav Manojkumar Modi Rajiv Indravadan Khamar Bakulesh Mafatlal |
| description | The present invention relates to a lyophilized composition comprising killed cancer cells with substantially retained immunogenicity and morphology, an intracellular cryopreservative such as trehalose and an extracellular cryopreservative such as polyvinylpyrrolidone. The present invention also relates to a process for the preparation of said lyophilized composition. The lyophilized composition of the present invention can be used for cancer immunotherapy. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2018042850A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2018042850A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2018042850A13</originalsourceid><addsrcrecordid>eNqNzTEKwkAQQNE0FqLeYcBaSKJCWlkUxUaMqcOYTMzA7G5wZ5Hc3hQewOo3D_48qW49vi02FJUbFDDeDj6wsnfgO7iyCLVgSCTAh7WHMj6DolNGkRHupMhuEhdro_Mvctywjstk1qEEWv26SNan48OcNzT4msIw_RxpXZV5mhXpLi_26SHb_qe-AAE6qA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity</title><source>esp@cenet</source><creator>Singh Satinder ; Desai Nirav Manojkumar ; Modi Rajiv Indravadan ; Khamar Bakulesh Mafatlal</creator><creatorcontrib>Singh Satinder ; Desai Nirav Manojkumar ; Modi Rajiv Indravadan ; Khamar Bakulesh Mafatlal</creatorcontrib><description>The present invention relates to a lyophilized composition comprising killed cancer cells with substantially retained immunogenicity and morphology, an intracellular cryopreservative such as trehalose and an extracellular cryopreservative such as polyvinylpyrrolidone. The present invention also relates to a process for the preparation of said lyophilized composition. The lyophilized composition of the present invention can be used for cancer immunotherapy.</description><language>eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180215&DB=EPODOC&CC=US&NR=2018042850A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180215&DB=EPODOC&CC=US&NR=2018042850A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Singh Satinder</creatorcontrib><creatorcontrib>Desai Nirav Manojkumar</creatorcontrib><creatorcontrib>Modi Rajiv Indravadan</creatorcontrib><creatorcontrib>Khamar Bakulesh Mafatlal</creatorcontrib><title>Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity</title><description>The present invention relates to a lyophilized composition comprising killed cancer cells with substantially retained immunogenicity and morphology, an intracellular cryopreservative such as trehalose and an extracellular cryopreservative such as polyvinylpyrrolidone. The present invention also relates to a process for the preparation of said lyophilized composition. The lyophilized composition of the present invention can be used for cancer immunotherapy.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNzTEKwkAQQNE0FqLeYcBaSKJCWlkUxUaMqcOYTMzA7G5wZ5Hc3hQewOo3D_48qW49vi02FJUbFDDeDj6wsnfgO7iyCLVgSCTAh7WHMj6DolNGkRHupMhuEhdro_Mvctywjstk1qEEWv26SNan48OcNzT4msIw_RxpXZV5mhXpLi_26SHb_qe-AAE6qA</recordid><startdate>20180215</startdate><enddate>20180215</enddate><creator>Singh Satinder</creator><creator>Desai Nirav Manojkumar</creator><creator>Modi Rajiv Indravadan</creator><creator>Khamar Bakulesh Mafatlal</creator><scope>EVB</scope></search><sort><creationdate>20180215</creationdate><title>Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity</title><author>Singh Satinder ; Desai Nirav Manojkumar ; Modi Rajiv Indravadan ; Khamar Bakulesh Mafatlal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2018042850A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>Singh Satinder</creatorcontrib><creatorcontrib>Desai Nirav Manojkumar</creatorcontrib><creatorcontrib>Modi Rajiv Indravadan</creatorcontrib><creatorcontrib>Khamar Bakulesh Mafatlal</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Singh Satinder</au><au>Desai Nirav Manojkumar</au><au>Modi Rajiv Indravadan</au><au>Khamar Bakulesh Mafatlal</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity</title><date>2018-02-15</date><risdate>2018</risdate><abstract>The present invention relates to a lyophilized composition comprising killed cancer cells with substantially retained immunogenicity and morphology, an intracellular cryopreservative such as trehalose and an extracellular cryopreservative such as polyvinylpyrrolidone. The present invention also relates to a process for the preparation of said lyophilized composition. The lyophilized composition of the present invention can be used for cancer immunotherapy.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2018042850A1 |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Pharmaceutical Composition of Killed Cells with Substantially Retained Immunogenicity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A35%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Singh%20Satinder&rft.date=2018-02-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2018042850A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |